This company listing is no longer active
Probiotec Toekomstige groei
Future criteriumcontroles 1/6
Probiotec is forecast to grow revenue at 6.7% per annum.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 54.0% |
Inkomstengroei | 6.7% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 28 Feb 2024 |
Recente toekomstige groei-updates
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
6/30/2026 | 264 | N/A | 18 | 35 | 1 |
6/30/2025 | 253 | N/A | 18 | 30 | 1 |
6/30/2024 | 238 | N/A | 12 | 22 | 1 |
12/31/2023 | 221 | 9 | 5 | 16 | N/A |
9/30/2023 | 218 | 10 | 6 | 16 | N/A |
6/30/2023 | 214 | 11 | 7 | 17 | N/A |
3/31/2023 | 209 | 13 | 8 | 18 | N/A |
12/31/2022 | 204 | 15 | 10 | 18 | N/A |
9/30/2022 | 193 | 14 | 11 | 19 | N/A |
6/30/2022 | 182 | 14 | 13 | 20 | N/A |
12/31/2021 | 163 | 8 | 23 | 28 | N/A |
9/30/2021 | 142 | 7 | 22 | 26 | N/A |
6/30/2021 | 121 | 5 | 20 | 24 | N/A |
12/31/2020 | 106 | 6 | 6 | 10 | N/A |
9/30/2020 | 106 | 6 | 8 | 10 | N/A |
6/30/2020 | 107 | 6 | 10 | 10 | N/A |
3/31/2020 | 96 | 5 | 7 | 9 | N/A |
12/31/2019 | 84 | 4 | 5 | 8 | N/A |
9/30/2019 | 79 | 4 | 5 | 2 | N/A |
6/30/2019 | 73 | 4 | 5 | -4 | N/A |
3/31/2019 | 73 | 4 | 7 | -3 | N/A |
12/31/2018 | 72 | 4 | 9 | -2 | N/A |
9/30/2018 | 69 | 3 | 5 | 2 | N/A |
6/30/2018 | 66 | 3 | 1 | 6 | N/A |
12/31/2017 | 60 | 2 | 4 | 7 | N/A |
9/30/2017 | 61 | 3 | N/A | 6 | N/A |
6/30/2017 | 61 | 3 | N/A | 4 | N/A |
12/31/2016 | 63 | 3 | N/A | 6 | N/A |
9/30/2016 | 64 | 3 | N/A | 5 | N/A |
6/30/2016 | 66 | 2 | N/A | 5 | N/A |
12/31/2015 | 64 | 1 | N/A | 2 | N/A |
9/30/2015 | 64 | 1 | N/A | 2 | N/A |
6/30/2015 | 63 | 0 | N/A | 2 | N/A |
12/31/2014 | 65 | -1 | N/A | 3 | N/A |
9/30/2014 | 67 | 0 | N/A | 4 | N/A |
6/30/2014 | 68 | 1 | N/A | 5 | N/A |
12/31/2013 | 65 | 2 | N/A | 6 | N/A |
9/30/2013 | 66 | 2 | N/A | 6 | N/A |
6/30/2013 | 67 | 1 | N/A | 5 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if PBP's forecast earnings growth is above the savings rate (2.3%).
Winst versus markt: Insufficient data to determine if PBP's earnings are forecast to grow faster than the Australian market
Hoge groeiwinsten: Insufficient data to determine if PBP's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: PBP's revenue (6.7% per year) is forecast to grow faster than the Australian market (5.4% per year).
Hoge groei-inkomsten: PBP's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if PBP's Return on Equity is forecast to be high in 3 years time